Global Oral Mesalazine Market Growth (Status and Outlook) 2026-2032

April 2026 | 87 pages | ID: GC9B9D8C53DDEN
LP Information

Abstracts

The global Oral Mesalazine market size is predicted to grow from US$ 94.21 million in 2025 to US$ 122 million in 2032; it is expected to grow at a CAGR of 3.8% from 2026 to 2032.

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the ?Oral Mesalazine Industry Forecast? looks at past sales and reviews total world Oral Mesalazine sales in 2025, providing a comprehensive analysis by region and market sector of projected Oral Mesalazine sales for 2026 through 2032. With Oral Mesalazine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Mesalazine industry.

This Insight Report provides a comprehensive analysis of the global Oral Mesalazine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Mesalazine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oral Mesalazine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Mesalazine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Mesalazine.

This report presents a comprehensive overview, market shares, and growth opportunities of Oral Mesalazine market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Tablets
• Capsules
• Granule

Segmentation by Application:

• Ulcerative Colitis
• Crohn's Disease
• Inflammatory Bowel Disease
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AbbVie
• Shire
• Salix Pharmaceuticals
• Ferring Global
• Teva Pharmaceutical Industries
• Morningside Healthcare
• Dr. Falk Pharma UK
• Nogra Pharma Limited
• Tillotts Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oral Mesalazine Market Size (2021-2032)
  2.1.2 Oral Mesalazine Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Oral Mesalazine by Country/Region (2021, 2025 & 2032)
2.2 Oral Mesalazine Segment by Type
  2.2.1 Tablets
  2.2.2 Capsules
  2.2.3 Granule
  2.2.4 Oral Mesalazine Market Size by Type
    2.2.4.1 Oral Mesalazine Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Oral Mesalazine Market Size Market Share by Type (2021-2026)
2.3 Oral Mesalazine Segment by Application
  2.3.1 Ulcerative Colitis
  2.3.2 Crohn's Disease
  2.3.3 Inflammatory Bowel Disease
  2.3.4 Others
  2.3.5 Oral Mesalazine Market Size by Application
    2.3.5.1 Oral Mesalazine Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.5.2 Global Oral Mesalazine Market Size Market Share by Application (2021-2026)

3 ORAL MESALAZINE MARKET SIZE BY PLAYER

3.1 Oral Mesalazine Market Size Market Share by Player
  3.1.1 Global Oral Mesalazine Revenue by Player (2021-2026)
  3.1.2 Global Oral Mesalazine Revenue Market Share by Player (2021-2026)
3.2 Global Oral Mesalazine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ORAL MESALAZINE BY REGION

4.1 Oral Mesalazine Market Size by Region (2021-2026)
4.2 Global Oral Mesalazine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oral Mesalazine Market Size Growth (2021-2026)
4.4 APAC Oral Mesalazine Market Size Growth (2021-2026)
4.5 Europe Oral Mesalazine Market Size Growth (2021-2026)
4.6 Middle East & Africa Oral Mesalazine Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Oral Mesalazine Market Size by Country (2021-2026)
5.2 Americas Oral Mesalazine Market Size by Type (2021-2026)
5.3 Americas Oral Mesalazine Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oral Mesalazine Market Size by Region (2021-2026)
6.2 APAC Oral Mesalazine Market Size by Type (2021-2026)
6.3 APAC Oral Mesalazine Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oral Mesalazine Market Size by Country (2021-2026)
7.2 Europe Oral Mesalazine Market Size by Type (2021-2026)
7.3 Europe Oral Mesalazine Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oral Mesalazine by Region (2021-2026)
8.2 Middle East & Africa Oral Mesalazine Market Size by Type (2021-2026)
8.3 Middle East & Africa Oral Mesalazine Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ORAL MESALAZINE MARKET FORECAST

10.1 Global Oral Mesalazine Forecast by Region (2027-2032)
  10.1.1 Global Oral Mesalazine Forecast by Region (2027-2032)
  10.1.2 Americas Oral Mesalazine Forecast
  10.1.3 APAC Oral Mesalazine Forecast
  10.1.4 Europe Oral Mesalazine Forecast
  10.1.5 Middle East & Africa Oral Mesalazine Forecast
10.2 Americas Oral Mesalazine Forecast by Country (2027-2032)
  10.2.1 United States Market Oral Mesalazine Forecast
  10.2.2 Canada Market Oral Mesalazine Forecast
  10.2.3 Mexico Market Oral Mesalazine Forecast
  10.2.4 Brazil Market Oral Mesalazine Forecast
10.3 APAC Oral Mesalazine Forecast by Region (2027-2032)
  10.3.1 China Oral Mesalazine Market Forecast
  10.3.2 Japan Market Oral Mesalazine Forecast
  10.3.3 Korea Market Oral Mesalazine Forecast
  10.3.4 Southeast Asia Market Oral Mesalazine Forecast
  10.3.5 India Market Oral Mesalazine Forecast
  10.3.6 Australia Market Oral Mesalazine Forecast
10.4 Europe Oral Mesalazine Forecast by Country (2027-2032)
  10.4.1 Germany Market Oral Mesalazine Forecast
  10.4.2 France Market Oral Mesalazine Forecast
  10.4.3 UK Market Oral Mesalazine Forecast
  10.4.4 Italy Market Oral Mesalazine Forecast
  10.4.5 Russia Market Oral Mesalazine Forecast
10.5 Middle East & Africa Oral Mesalazine Forecast by Region (2027-2032)
  10.5.1 Egypt Market Oral Mesalazine Forecast
  10.5.2 South Africa Market Oral Mesalazine Forecast
  10.5.3 Israel Market Oral Mesalazine Forecast
  10.5.4 Turkey Market Oral Mesalazine Forecast
10.6 Global Oral Mesalazine Forecast by Type (2027-2032)
10.7 Global Oral Mesalazine Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Oral Mesalazine Forecast

11 KEY PLAYERS ANALYSIS

11.1 AbbVie
  11.1.1 AbbVie Company Information
  11.1.2 AbbVie Oral Mesalazine Product Offered
  11.1.3 AbbVie Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 AbbVie Main Business Overview
  11.1.5 AbbVie Latest Developments
11.2 Shire
  11.2.1 Shire Company Information
  11.2.2 Shire Oral Mesalazine Product Offered
  11.2.3 Shire Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Shire Main Business Overview
  11.2.5 Shire Latest Developments
11.3 Salix Pharmaceuticals
  11.3.1 Salix Pharmaceuticals Company Information
  11.3.2 Salix Pharmaceuticals Oral Mesalazine Product Offered
  11.3.3 Salix Pharmaceuticals Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Salix Pharmaceuticals Main Business Overview
  11.3.5 Salix Pharmaceuticals Latest Developments
11.4 Ferring Global
  11.4.1 Ferring Global Company Information
  11.4.2 Ferring Global Oral Mesalazine Product Offered
  11.4.3 Ferring Global Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Ferring Global Main Business Overview
  11.4.5 Ferring Global Latest Developments
11.5 Teva Pharmaceutical Industries
  11.5.1 Teva Pharmaceutical Industries Company Information
  11.5.2 Teva Pharmaceutical Industries Oral Mesalazine Product Offered
  11.5.3 Teva Pharmaceutical Industries Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Teva Pharmaceutical Industries Main Business Overview
  11.5.5 Teva Pharmaceutical Industries Latest Developments
11.6 Morningside Healthcare
  11.6.1 Morningside Healthcare Company Information
  11.6.2 Morningside Healthcare Oral Mesalazine Product Offered
  11.6.3 Morningside Healthcare Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 Morningside Healthcare Main Business Overview
  11.6.5 Morningside Healthcare Latest Developments
11.7 Dr. Falk Pharma UK
  11.7.1 Dr. Falk Pharma UK Company Information
  11.7.2 Dr. Falk Pharma UK Oral Mesalazine Product Offered
  11.7.3 Dr. Falk Pharma UK Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Dr. Falk Pharma UK Main Business Overview
  11.7.5 Dr. Falk Pharma UK Latest Developments
11.8 Nogra Pharma Limited
  11.8.1 Nogra Pharma Limited Company Information
  11.8.2 Nogra Pharma Limited Oral Mesalazine Product Offered
  11.8.3 Nogra Pharma Limited Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Nogra Pharma Limited Main Business Overview
  11.8.5 Nogra Pharma Limited Latest Developments
11.9 Tillotts Pharma
  11.9.1 Tillotts Pharma Company Information
  11.9.2 Tillotts Pharma Oral Mesalazine Product Offered
  11.9.3 Tillotts Pharma Oral Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 Tillotts Pharma Main Business Overview
  11.9.5 Tillotts Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oral Mesalazine Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oral Mesalazine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players ofTablets
Table 4. Major Players of Capsules
Table 5. Major Players of Granule
Table 6. Oral Mesalazine Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Oral Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Oral Mesalazine Market Size Market Share by Type (2021-2026)
Table 9. Oral Mesalazine Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Oral Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Oral Mesalazine Market Size Market Share by Application (2021-2026)
Table 12. Global Oral Mesalazine Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Oral Mesalazine Revenue Market Share by Player (2021-2026)
Table 14. Oral Mesalazine Key Players Head office and Products Offered
Table 15. Oral Mesalazine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oral Mesalazine Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Oral Mesalazine Market Size Market Share by Region (2021-2026)
Table 20. Global Oral Mesalazine Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Oral Mesalazine Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Oral Mesalazine Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Oral Mesalazine Market Size Market Share by Country (2021-2026)
Table 24. Americas Oral Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Oral Mesalazine Market Size Market Share by Type (2021-2026)
Table 26. Americas Oral Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Oral Mesalazine Market Size Market Share by Application (2021-2026)
Table 28. APAC Oral Mesalazine Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Oral Mesalazine Market Size Market Share by Region (2021-2026)
Table 30. APAC Oral Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Oral Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Oral Mesalazine Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Oral Mesalazine Market Size Market Share by Country (2021-2026)
Table 34. Europe Oral Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Oral Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Oral Mesalazine Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Oral Mesalazine Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Oral Mesalazine Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Oral Mesalazine
Table 40. Key Market Challenges & Risks of Oral Mesalazine
Table 41. Key Industry Trends of Oral Mesalazine
Table 42. Global Oral Mesalazine Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Oral Mesalazine Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Oral Mesalazine Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Oral Mesalazine Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. AbbVie Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 47. AbbVie Oral Mesalazine Product Offered
Table 48. AbbVie Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. AbbVie Main Business
Table 50. AbbVie Latest Developments
Table 51. Shire Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 52. Shire Oral Mesalazine Product Offered
Table 53. Shire Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Shire Main Business
Table 55. Shire Latest Developments
Table 56. Salix Pharmaceuticals Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 57. Salix Pharmaceuticals Oral Mesalazine Product Offered
Table 58. Salix Pharmaceuticals Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Salix Pharmaceuticals Main Business
Table 60. Salix Pharmaceuticals Latest Developments
Table 61. Ferring Global Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 62. Ferring Global Oral Mesalazine Product Offered
Table 63. Ferring Global Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Ferring Global Main Business
Table 65. Ferring Global Latest Developments
Table 66. Teva Pharmaceutical Industries Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 67. Teva Pharmaceutical Industries Oral Mesalazine Product Offered
Table 68. Teva Pharmaceutical Industries Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Teva Pharmaceutical Industries Main Business
Table 70. Teva Pharmaceutical Industries Latest Developments
Table 71. Morningside Healthcare Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 72. Morningside Healthcare Oral Mesalazine Product Offered
Table 73. Morningside Healthcare Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Morningside Healthcare Main Business
Table 75. Morningside Healthcare Latest Developments
Table 76. Dr. Falk Pharma UK Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 77. Dr. Falk Pharma UK Oral Mesalazine Product Offered
Table 78. Dr. Falk Pharma UK Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Dr. Falk Pharma UK Main Business
Table 80. Dr. Falk Pharma UK Latest Developments
Table 81. Nogra Pharma Limited Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 82. Nogra Pharma Limited Oral Mesalazine Product Offered
Table 83. Nogra Pharma Limited Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Nogra Pharma Limited Main Business
Table 85. Nogra Pharma Limited Latest Developments
Table 86. Tillotts Pharma Details, Company Type, Oral Mesalazine Area Served and Its Competitors
Table 87. Tillotts Pharma Oral Mesalazine Product Offered
Table 88. Tillotts Pharma Oral Mesalazine Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Tillotts Pharma Main Business
Table 90. Tillotts Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oral Mesalazine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oral Mesalazine Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oral Mesalazine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oral Mesalazine Sales Market Share by Country/Region (2025)
Figure 8. Oral Mesalazine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oral Mesalazine Market Size Market Share by Type in 2025
Figure 10. Oral Mesalazine in Ulcerative Colitis
Figure 11. Global Oral Mesalazine Market: Ulcerative Colitis (2021-2026) & ($ millions)
Figure 12. Oral Mesalazine in Crohn's Disease
Figure 13. Global Oral Mesalazine Market: Crohn's Disease (2021-2026) & ($ millions)
Figure 14. Oral Mesalazine in Inflammatory Bowel Disease
Figure 15. Global Oral Mesalazine Market: Inflammatory Bowel Disease (2021-2026) & ($ millions)
Figure 16. Oral Mesalazine in Others
Figure 17. Global Oral Mesalazine Market: Others (2021-2026) & ($ millions)
Figure 18. Global Oral Mesalazine Market Size Market Share by Application in 2025
Figure 19. Global Oral Mesalazine Revenue Market Share by Player in 2025
Figure 20. Global Oral Mesalazine Market Size Market Share by Region (2021-2026)
Figure 21. Americas Oral Mesalazine Market Size 2021-2026 ($ millions)
Figure 22. APAC Oral Mesalazine Market Size 2021-2026 ($ millions)
Figure 23. Europe Oral Mesalazine Market Size 2021-2026 ($ millions)
Figure 24. Middle East & Africa Oral Mesalazine Market Size 2021-2026 ($ millions)
Figure 25. Americas Oral Mesalazine Value Market Share by Country in 2025
Figure 26. United States Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 27. Canada Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 28. Mexico Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 29. Brazil Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 30. APAC Oral Mesalazine Market Size Market Share by Region in 2025
Figure 31. APAC Oral Mesalazine Market Size Market Share by Type (2021-2026)
Figure 32. APAC Oral Mesalazine Market Size Market Share by Application (2021-2026)
Figure 33. China Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 34. Japan Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 35. South Korea Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 36. Southeast Asia Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 37. India Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 38. Australia Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 39. Europe Oral Mesalazine Market Size Market Share by Country in 2025
Figure 40. Europe Oral Mesalazine Market Size Market Share by Type (2021-2026)
Figure 41. Europe Oral Mesalazine Market Size Market Share by Application (2021-2026)
Figure 42. Germany Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 43. France Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 44. UK Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 45. Italy Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 46. Russia Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 47. Middle East & Africa Oral Mesalazine Market Size Market Share by Region (2021-2026)
Figure 48. Middle East & Africa Oral Mesalazine Market Size Market Share by Type (2021-2026)
Figure 49. Middle East & Africa Oral Mesalazine Market Size Market Share by Application (2021-2026)
Figure 50. Egypt Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 51. South Africa Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 52. Israel Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 53. Turkey Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 54. GCC Countries Oral Mesalazine Market Size Growth 2021-2026 ($ millions)
Figure 55. Americas Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 56. APAC Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 57. Europe Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 58. Middle East & Africa Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 59. United States Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 60. Canada Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 61. Mexico Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 62. Brazil Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 63. China Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 64. Japan Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 65. Korea Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 66. Southeast Asia Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 67. India Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 68. Australia Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 69. Germany Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 70. France Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 71. UK Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 72. Italy Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 73. Russia Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 74. Egypt Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 75. South Africa Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 76. Israel Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 77. Turkey Oral Mesalazine Market Size 2027-2032 ($ millions)
Figure 78. Global Oral Mesalazine Market Size Market Share Forecast by Type (2027-2032)
Figure 79. Global Oral Mesalazine Market Size Market Share Forecast by Application (2027-2032)
Figure 80. GCC Countries Oral Mesalazine Market Size 2027-2032 ($ millions)